These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15630839)

  • 1. The role of the optimal healing environment in the care of patients with diabetes mellitus type II.
    Kligler B
    J Altern Complement Med; 2004; 10 Suppl 1():S223-9. PubMed ID: 15630839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Allocation of resources for the health care of diabetics. Panel of Experts, Ministry of Health and Consumption].
    Aten Primaria; 1996 Apr; 17(7):471-9. PubMed ID: 8679881
    [No Abstract]   [Full Text] [Related]  

  • 3. Optimal healing environments for chronic cardiovascular disease.
    Marshall DA; Walizer E; Vernalis MN
    J Altern Complement Med; 2004; 10 Suppl 1():S147-55. PubMed ID: 15630832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Polish Multicenter Study on Diabetes Epidemiology (PMSDE)--1998-2000].
    Szybiński Z
    Pol Arch Med Wewn; 2001 Sep; 106(3):751-8. PubMed ID: 11928582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recommendations and guidelines regarding the preferred research protocol for investigating the impact of an optimal healing environment on patients with substance abuse.
    Wesa KM; Culliton P
    J Altern Complement Med; 2004; 10 Suppl 1():S193-9. PubMed ID: 15630836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal healing environments in end-of-life care and beyond.
    Silver S
    J Altern Complement Med; 2004; 10 Suppl 1():S201-9. PubMed ID: 15630837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recommendations and guidelines regarding the preferred research protocol for investigating the impact of an optimal healing environment on patients with hypertension.
    Wesa KM; Grimm RH
    J Altern Complement Med; 2004; 10 Suppl 1():S245-50. PubMed ID: 15630841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conceptualization and evaluation of an optimal healing environment for chronic low-back pain in primary care.
    Cherkin D; Sherman KJ
    J Altern Complement Med; 2004; 10 Suppl 1():S171-8. PubMed ID: 15630834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A desktop guide to Type 2 diabetes mellitus. European Diabetes Policy Group 1999.
    Diabet Med; 1999 Sep; 16(9):716-30. PubMed ID: 10510947
    [No Abstract]   [Full Text] [Related]  

  • 10. The Mental Health in Diabetes Service (MINDS) to enhance psychosocial health: study protocol for a randomized controlled trial.
    O'Brien CL; Ski CF; Thompson DR; Moore G; Mancuso S; Jenkins A; Ward G; MacIsaac RJ; Loh M; Knowles SR; Rossell SL; Castle DJ
    Trials; 2016 Sep; 17(1):444. PubMed ID: 27612943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Designing relational models of collaborative integrative medicine that support healing processes.
    Bolles S; Maley M
    J Altern Complement Med; 2004; 10 Suppl 1():S61-9. PubMed ID: 15630823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complications of type 2 diabetes mellitus: a brief overview.
    Schorr AB
    J Am Osteopath Assoc; 1999 Dec; 99(12 Suppl):S10-4. PubMed ID: 10659524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evaluation of the DEXLIFE 'self-selected' lifestyle intervention aimed at improving insulin sensitivity in people at risk of developing type 2 diabetes: study protocol for a randomised controlled trial.
    O'Donoghue GM; Kennedy A; Andersen GS; Durkan E; Thybo T; Sinnott M; Nolan JJ; O'Gorman DJ
    Trials; 2015 Nov; 16():529. PubMed ID: 26581687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of optimal healing environments in patients undergoing cancer treatment: clinical research protocol guidelines.
    Block KI; Block P; Gyllenhaal C
    J Altern Complement Med; 2004; 10 Suppl 1():S157-70. PubMed ID: 15630833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standards of medical care in diabetes.
    American Diabetes Association
    Diabetes Care; 2005 Jan; 28 Suppl 1():S4-S36. PubMed ID: 15618112
    [No Abstract]   [Full Text] [Related]  

  • 16. ISPAD Clinical Practice Consensus Guidelines 2014. Microvascular and macrovascular complications in children and adolescents.
    Donaghue KC; Wadwa RP; Dimeglio LA; Wong TY; Chiarelli F; Marcovecchio ML; Salem M; Raza J; Hofman PL; Craig ME;
    Pediatr Diabetes; 2014 Sep; 15 Suppl 20():257-69. PubMed ID: 25182318
    [No Abstract]   [Full Text] [Related]  

  • 17. Effectiveness of the cardiac-diabetes transcare program: protocol for a randomised controlled trial.
    Wu CJ; Atherton JJ; MacIsaac RJ; Courtney M; Chang AM; Thompson DR; Kostner K; MacIsaac AI; d'Emden M; Graves N; McPhail SM
    BMC Health Serv Res; 2017 Feb; 17(1):109. PubMed ID: 28153000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention and treatment of the complications of diabetes mellitus.
    Clark CM; Lee DA
    N Engl J Med; 1995 May; 332(18):1210-7. PubMed ID: 7700316
    [No Abstract]   [Full Text] [Related]  

  • 19. Interactions between microvascular and macrovascular disease in diabetes: pathophysiology and therapeutic implications.
    Krentz AJ; Clough G; Byrne CD
    Diabetes Obes Metab; 2007 Nov; 9(6):781-91. PubMed ID: 17924862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standards of care for diabetes.
    Weir GC; Nathan DM; Singer DE
    Diabetes Care; 1994 Dec; 17(12):1514-22. PubMed ID: 7882829
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.